About Us

ZENOGEN PHARMA pursues advances in life sciences that contribute to people’s health and welfare worldwide. We are always grateful to everyone who has supported and engaged with us, and we will continue to grow and improve to address evolving societal needs.

CELLBANKER is a series of cell cryopreservation media. Since its commercial launch in 1991, it has become widely popular among researchers and customers of interest in biotechnology. The introduction of CELLBANKER made cell cryopreservation more convenient and significantly enhanced its efficiency, leading to a strong recognition in the scientific community. Moreover, breakthroughs such as induced pluripotent stem cells (iPS cells) have further expanded the potential of CELLBANKER.

Remarkable progress in the therapeutic application of cells and tissues has underscored the importance of cell preservation in research, development, and manufacturing. To meet these evolving needs, we strive to enhance our products and services to support our customers more effectively. Through these efforts, we aim to contribute to the success of drug development and the advancement of treatments that improve the quality of life for patients.

CELLBANKER is more than just a product; it serves as a trusted partner in advancing medical research and working alongside researchers. We deeply value feedback from our customers and partners as we continue our journey to becoming an indispensable part of the biological and pharmaceutical industries.

Masato Fukui, CEO

Corporate Profile

Corporate Name
ZENOGEN PHARMA CO., LTD.
Office
1-1 Tairanoue, Sasagawa, Asaka-machi, Koriyama, Fukushima, 963-0196 Japan
Representative
Masato Fukui
Date of Establishment
April 1985
Core Business
Research, development, manufacturing, and sales of products and services related to the life science field.